1. Home
  2. LYCA

LYCA

Lycia Therapeutics Inc. Common Stock

as of 11-20-2026 3:40pm EST

$32.94
+$0.95
+2.97%
Stocks Health Care Biotechnology: Biological Products (No Diagnostic Substances) Nasdaq
Founded: 2019 Country:
United States
United States
Employees: N/A City: N/A
Market Cap: 1.4B IPO Year: 2026
Target Price: $54.00 AVG Volume (30 days): 250.4K
Analyst Decision: Strong Buy Number of Analysts: 5
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $25.66 - $33.56 Next Earning Date: 12-01-2026
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): -100% Revenue Growth (next year): N/A
P/E Ratio: N/A Index: N/A
Free Cash Flow: N/A FCF Growth: N/A

Stock Insider Trading Activity of Lycia Therapeutics Inc. Common Stock (LYCA)

LYCA Nov 2, 2026

Avg Cost/Share

$26.95

Shares

8,305

Total Value

$223,819.75

Owned After

6,858,542

SEC Form 4

Share on Social Networks: